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sSurvival  for  very  low  birthweight  (VLBW)  infants  has
improved  dramatically  over  the  last  2  decades.  This  has
shifted  the  aim  of  neonatal  care  from  one  that  focuses
purely  on  short  term  survival  to  one  that  considers  the
life-long  impacts  of  preterm  birth.1 Neonatologists  must,
of  course,  continue  to  strengthen  their  efforts  to  reduce
key  neonatal  morbidities  such  as  necrotizing  enterocolitis,
sepsis  and  chronic  lung  disease,  but  must  now  consider  the
impact  of  nutrition  and  other  interventions  over  the  life
course.  There  are  strong  data  to  show  that  improved  neuro-
cognitive  outcomes  are  associated  with  higher  early  nutrient
intakes.  However,  the  emerging  discipline  of  ‘Developmen-
tal  Origins  of  Health  and  Disease’  (DOHaD)  has  increased
awareness  of  the  associations  between  higher  nutrient
intakes  and  more  rapid  growth  in  early  life  and  worse
long-term  metabolic  outcomes  such  as  cardio-vascular
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).isease  and  type  2  diabetes.2,3 This  risk  seems  especially
igh  in  those  who  are  born  in  utero  growth-restricted
IUGR),  but  the  independent  impact  of  prematurity  has
ot  been  well  studied.4 The  paper  by  Heidemann  et  al.5
s  important  because  it  highlights  the  issue  that  adverse
etabolic  effects  may  be  apparent  in  early  infancy  in  those
orn  preterm,  and  asks  clinicians  to  consider  what  practical
teps  can  be  taken  to  reduce  their  later  life  consequences.
Heidemann’s  cross  sectional  study  included  VLBW
reterm  infants  recruited  from  a  single  tertiary  center  in
razil  who  were  followed  up  in  a  well  organized  outpatient
linic,  and  explored  the  relationship  of  early  neonatal  expo-
ures  on  later  metabolic  syndrome-like  symptoms  (MSL).
efining  the  ‘metabolic  syndrome’  in  childhood  is  challeng-
ng  and  few  comparable  studies  exist;  furthermore  there
re  no  agreed  standards  or  definitions  that  allow  a  com-
rehensive  diagnosis,  and  virtually  no  longitudinal  data
xist.  Using  a  valid  and  practical  definition  of  the  metabolic
yndrome  is  therefore  challenging,  but  many  studies  have
xplored  insulin  resistance  in  the  context  of  DOHaD.6 Hei-
emann  et  al.  used  a  similar  definition  to  that  developed  to
7escribe  an  abnormal  metabolic  phenotype  in  adolescents,
ut  whether  such  a  definition  will  ultimately  be  shown  to  be
 valid  and  robust  marker  of  later  outcomes  when  applied
n  infancy  remains  to  be  determined.
r Editora Ltda. This is an open access article under the CC BY-NC-ND
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Follow-up  studies  of  children  born  preterm  are  notori-
usly  difficult,  and  even  the  well-recognised  international
ohorts  suffer  from  important  attritional  losses  over  time.8
n  Heidemann’s  study,  children  who  attended  at  least  3
ollow-up  visits  were  eligible  for  inclusion.  Nevertheless,
t  is  important  to  consider  the  possibility  that  those  who
ttended  for  frequent  follow-up  may  not  be  representative
f  those  who  were  in-frequent  attenders,  or  worse  still,
hose  who  did  not  attend  at  all.  Data  from  other  settings
uggest  those  at  highest  risk  of  morbidities  may  sometimes
e  the  most  difficult  to  follow  up.9 Families  from  less  afflu-
nt  backgrounds  may  struggle  with  costs  of  transport  to
ttend  clinics,  or  the  costs  of  taking  time  off  work,  and
ay  live  in  environments  with  less  access  to  exercise  and
pportunities  for  physical  activity.  These  children  may  also
ave  different  background  rates  of  breastfeeding,  or  be  fed
sing  sub-optimal  diets  during  early  infancy.  Adjusting  for
uch  factors  in  observational  studies  is  extremely  complex,
nd  even  then,  determining  whether  they  are  on  the  causal
athway  to  MSL  is  challenging  using  observational  cohort
esigns.
The  study  recorded  a  range  of  neonatal  variables,  includ-
ng  nutritional  exposures  such  as  the  use  of  amino  acids
n  parenteral  nutrition  (PN)  in  the  first  24  h  of  life.  The
enefits  and  risks  of  early  PN  remain  uncertain  although
ost  NICUs  now  consider  it  routine.10 There  was  no  evi-
ence  that  early  PN  exposure  increased  the  later  risk  of
SL,  but  the  data  collection  and  analysis  was  not  able  to
ccount  for  actual  macronutrient  intakes  either  from  PN  or
ubsequent  enteral  intakes  whilst  on  the  Neonatal  Inten-
ive  Care  Unit  (NICU).  Data  from  term  infants  show  that
ncreased  dietary  protein  intakes  most  often  through  the
onsumption  of  infant  formula  milk  (that  has  higher  pro-
ein  concentrations  than  breastmilk)  are  associated  with  an
ncreased  risk  of  later  obesity.11 Preliminary  data  suggest
he  effect  is  likely  to  be  mediated  through  IGF-1  and  other
ndocrine  pathways.  Whether  similar  long-term  adverse  MSL
ffects  exist  in  VLBW  infants  is  uncertain.  However,  this
eeds  to  be  considered  alongside  the  data  that  show  that
GF-1  levels  in  VLBW  are  frequently  much  lower  than  fetal
eferences,  and  that  these  low  levels  may  themselves  impair
ptimal  brain  growth.12 It  is  possible,  therefore,  that  a  feed-
ng  strategy  on  the  NICU  that  optimizes  IGF-1  levels,  and
hus  brain  development,  may  also  increase  risks  of  later
besity.
Heidemann  et  al.5 also  explored  breast  feeding  status
t  6  months  of  age  and  the  occurrence  of  MSL  but  were
nable  to  demonstrate  any  association.  Data  from  other
ettings  demonstrate  that  breastfeeding  status  is  a  key  mod-
lator  of  later  metabolic  health  and  show  that  infants  who
ere  breast-fed  have  lower  blood  pressure  and  improved
one  health  in  later  life.13,14 Breast-milk  exhibits  a  dose-
esponse  effect  in  these  studies,  with  evidence  that  even  a
ew  months  of  breast-feeding  may  be  beneficial  for  neuro-
ognitive  outcomes  and  metabolic  health.  Breastmilk  may
herefore  be  important  even  when  it  is  not  exclusive,  and
here  it  doesn’t  continue  until  6  months  of  age,  as  recom-
ended  by  the  WHO  and  other  organizations.  Few  mothers
f  preterm  infants  are  able  to  maintain  breastfeeding  for
rolonged  lengths  of  time:  in  Heidemann’s  study  <15%  of
nfants  were  exclusively  breastfed  at  6  months  corrected
ge.
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Determining  the  impact  of  prematurity  per  se,  rather
han  the  events  leading  to  preterm  delivery  is  virtually
mpossible.  Preterm  birth  is  frequently  the  end  result  of
 compromised  pregnancy.  The  mothers  of  infants  in  this
tudy  may  have  had  pre-pregnancy  complications  such  as
ypertension,  obesity  or  diabetes.  Alternatively,  they  may
ave  developed  metabolic  or  other  complications  during
regnancy,  including  gestational  diabetes  and  placental  dys-
unction  that  either  predisposed  to  early  labor  or  was  severe
nough  to  justify  elective  delivery  by  cesarean  section.
ther  preterm  infants  may  have  been  relatively  healthy  as
 fetus,  and  been  born  vaginally,  but  may  have  been  born
rematurely  due  to  some  other  complication  such  as  cervi-
al  incompetence  or  other  factors  leading  to  spontaneous
reterm  delivery.  Determining  whether  the  MSL  observed  is
 reflection  of  in  utero  exposures,  or  simply  a  consequence
f  early  ex  utero  life  is  impossible.  In  the  study,  over  40%  of
he  infants  were  small  for  gestational  age  (SGA).  Whether
GA  in  this  study  is  an  indication  that  the  infants  were  IUGR
s  difficult  to  determine.  Importantly,  it  must  be  remem-
ered  that  it  is  possible  for  an  infant  to  be  IUGR  but  still
e  born  >10th  percentile.15 Whether  the  effects  observed
n  this  study  are  primarily  due  to  prematurity  or  to  IUGR  is
ifficult  to  determine.
The  prevalence  of  MSL  in  this  study  was  alarmingly  high,
ith  >75%  of  infants  having  at  least  one  abnormal  measure,
lthough  the  authors  acknowledge  that  the  true  preva-
ence  of  abnormal  metabolism  may  be  lower.  Regardless,
his  appears  substantially  higher  than  at  least  one  other
ontemporary  Brazilian  study.16 Around  25--30%  of  infants
n  Heidemann’s  study  appear  to  have  some  evidence  of
bnormal  lipid  profiles  but  there  are  few  comparable  data,
nd  it  is  difficult  to  know  whether  such  abnormalities  will
rack  into  later  life.  There  are  overwhelming  data  to  show
hat  rates  of  childhood  obesity  are  rising  around  the  world,
eaching  epidemic  levels  in  some  countries.  In  this  study
lmost  20%  of  infants  were  classified  as  overweight  or  obese.
imilar  to  lipid  profiles,  it  is  difficult  to  know  how  obesity
n  infancy  may  reflect  measures  of  obesity  in  later  life  but
here  are  considerable  observational  data  to  show  that  chil-
ren  who  are  obese  are  much  more  likely  to  be  obese  as
dults.  This  may  reflect  ‘tracking’  of  obesity  throughout  life,
r  simply  reflect  the  fact  that  the  socio-demographic  factors
inked  to  obesity  in  childhood  are  also  likely  to  be  present
n  later  life.
Perhaps  most  concerning  is  the  high  prevalence  of  hyper-
ension:  57.5%  of  infants  had  high  blood  pressure,  and  those
ho  had  been  diagnosed  with  periventricular  leukomala-
ia  were  at  increased  risk  (OR  2.34).  These  findings  are
n  keeping  with  existing  literature  showing  increased  risks
f  hypertension  in  preterm  born  young  adults.17,18 Blood
ressure  also  appears  to  ‘track’  quite  strongly  into  later
ife  compared  with  other  measures  of  MSL19 and  raises  the
ossibility  that  small  differences  in  early  infancy  might
esult  in  big  differences  in  later  life.  In  the  large  Swedish
XPRESS  cohort  of  extremely  preterm  infants,  blood  pres-
ure  at  6  years  of  age  was  found  to  be  in  the  normal  range,
lthough  it  was  slightly  higher  than  term-born  peers.20 The
XPRESS  study  showed  there  were  no  strong  associations
ith  perinatal  variables,  but  blood  pressure  was  associated
ith  gestation  and  BMI.  Interestingly  they  had  shown  similar
ffects  at  2.5  years  similar  to  the  age  studied  by  Heidemann
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et  al.5 In  the  EXPRESS  study,  detailed  echocardiography
demonstrated  a  unique  cardiac  phenotype  characterized  by
a  smaller  left  ventricle  with  altered  systolic  and  diastolic
functions  than  same-aged  children  born  at  term.21 Hyperten-
sion  may  not  simply  be  a  marker  of  the  ‘metabolic  syndrome’
per  se,  but  it  reflects  differences  in  early  life  environments
that  permanently  change  cardiac  structure  due  to  the  fact
that  preterm  infant  cardiac  output  does  not  need  to  be
directed  back  toward  the  placenta.
The  mechanisms  by  which  the  early  life  of  VLBW  infants
might  program  later  metabolic  outcomes  are  numerous.
Animal  studies  have  demonstrated  a  range  of  possible  mech-
anisms  such  as  decreases  in  organ  size  (e.g.  decreased
early  nephron  number  or  growth),  altered  endocrine  set-
points,  DNA  methylation  or  other  epigenetic  changes,  and
permanent  alterations  to  the  gut  microbiome.22--24 Without
knowing  the  relative  contribution  each  of  these  mechanisms
may  play  it  is  difficult  to  know  how  we  might  best  reduce
or  prevent  these  later-life  complications.  It  is  also  possible
that  there  is  reverse  causation:  perhaps  infants  who  develop
later  hypertension  or  obesity  were  those  best  able  to  survive
the  challenges  of  very  premature  delivery?
So  what  practical  messages  can  clinicians  gain  from  this
study?  It  is  tempting  to  suggest  that  we  should  always
measure  blood  pressure  or  perform  echocardiography  in
follow-up  clinics,  but  what  would  we  do  with  the  findings,
and  would  this  simply  generate  parental  anxiety?  There  is
no  current  evidence  that  early  drug  intervention  is  benefi-
cial,  but  perhaps  children  born  preterm  should  be  offered
a  ‘‘routine  medical  review’’  when  they  become  adults?  But
who  would  provide  this  service  and  would  teenagers  and
young  adults  attend?  There  seems  to  be  no  harm  in  provid-
ing  healthy  lifestyle  advice  about  diet,  growth  and  physical
exercise;  indeed  other  follow-up  studies  in  preterm  children
have  shown  that  growth  patterns  after  infancy  were  much
stronger  predictors  of  abnormal  metabolism  in  early  adoles-
cence  than  NICU  or  infant  growth  and  nutrition.4 However,  it
is  difficult  to  provide  clear  advice  on  interventions  in  NICU
period  without  more  data:  restricting  catch-up  growth  or
nutrient  intake  at  a  critical  stage  of  development  may  do
more  harm  than  good.  Until  then,  clinicians  must  walk  the
tightrope  of  optimizing  survival  and  brain  outcomes  with
good  nutrition  (and  especially  mothers’  own  breast  milk)
in  early  life,  whilst  at  the  same  time  hoping  they  do  not
adversely  affect  later  metabolic  outcomes.
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